-
Study aim
-
Determining the effect of lidocaine injection in tracheal lumen on prevention of pulmonary infection in trauma patients under mechanical ventilation
-
Design
-
Randomized clinical trial with a control group, double-blind, randomized with rand (Excel) and randomized, with a sample size of 60 people.
-
Settings and conduct
-
In the intervention group, 1 mg per kilogram of body weight of 2% lidocaine without epinephrine will be injected into the tracheal lumen , 3 times a day for 72 hours, in the control group, the same amount of distilled water will be injected in the same period of time. On the morning of the fourth day, a sample of each patient's tracheal secretions will be sent to the laboratory for culture by an expert from the laboratory who is not aware of the intervention. The study is double-blinded (participants and Clinical caregiver ).
-
Participants/Inclusion and exclusion criteria
-
Entry: being under mechanical ventilation for more than three days, not receiving broad-spectrum antibiotics (fluoroquinolones, 3rd and 4th generation cephalosporins, carbapenems, tazosin and other broad-spectrum antibiotics) within 72 hours before the intervention, consent of companions First degree for participating in the study
Failure to enter: pulmonary disease (asthma, and COPD) and heart rhythm and rate disorders in the history taken from the patient's family
-
Intervention groups
-
Lidocaine without epinephrine will be injected into tracheal lumen of the patients of the intervention group for three days, and distilled water will be injected into the tracheal lumen of the patients of the control group during the same period. On the morning of the fourth day, samples of tracheal secretions will be taken from all the patients in order to compare the two groups in terms of pulmonary infection.
-
Main outcome variables
-
Reduction of pulmonary infection